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vPREFACE
This research presents two different applications of computational fluid mechanics
in the bio-engineering. In the first section of this thesis, the drug delivery in the
posterior eye has been simulated using the finite element method. The simulation
gives a valuable tool to the doctors who need to treat eye diseases with a specific
range of drug dosage. The second section in the thesis studies the wall shear stress
and velocity field in a rectangular duct. The accuracy of the measured shear stress
is then compared in boundary cells. Having an accurate computational model is
useful in bio-engineering and gives us better insight to understand the fluid-structure
interaction in bodily organs.
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ABSTRACT
Abootorabi, Seyedalireza, M.S.M.E, Purdue University, August 2020. Computational
Fluid Dynamics for Modeling and Simulation of Intraocular Drug Delivery and Wall
Shear Stress in Pulsatile Flow. Major Professor: Dr. Huidan Yu .
The thesis includes two application studies of computational fluid dynamics. The
first is new and efficient drug delivery to the posterior part of the eye, a growing health
necessity worldwide. Current treatment of eye diseases, such as age-related macular
degeneration (AMD), relies on repeated intravitreal injections of drug-containing so-
lutions. Such a drug delivery has significant drawbacks, including short drug life, vital
medical service, and high medical costs. In this study, we explore a new approach
of controlled drug delivery by introducing unique porous implants. Computational
modeling contains physiological and anatomical traits. We simulate the IgG1 Fab
drug delivery to the posterior eye to evaluate the effectiveness of the porous implants
to control the drug delivery. The computational model was validated by established
computation results from independent studies and experimental data. Overall, the
results indicate that therapeutic drug levels in the posterior eye are sustained for
eight weeks, similar to those performed with intravitreal injection of the same drug.
We evaluate the effects of the porous implant on the time evaluation of the drug
concentrations in the sclera, choroid, and retina layers of the eye. Subsequent simu-
lations were carried out with varying porosity values of a porous episcleral implant.
Our computational results reveal that the time evolution of drug concentration is
distinctively correlated to drug source location and pore size. The response of this
porous implant for controlled drug delivery applications was examined. A correlation
between porosity and fluid properties for the porous implants was revealed in this
study. The second application lays in the computational modeling of the oscillating
xiv
flow in rectangular ducts. This computational study has further applications in in-
vestigating the fluid flow motion in bodily organs. It can be useful in studying the
response of bone cells to the wall shear stress in the human body.
11. INTRODUCTION
The prevalence of computational fluid dynamics (CFD) has caused a revolution in
industrial and medical areas. Tackling problems in achieving high-performance com-
puting (HPC), visualizing data, and providing an infrastructure for optimized meth-
ods of simulations have provided us with many advancements in other fields and were
beneficial not only in the CFD realm. CFD is a powerful tool in harnessing informa-
tion in medical fields where the experimental measures are either hard or impossible.
In recent years, the Food and Drug Administration has put a lot of effort into fas-
tening the approval process for the medical products. They have used the CFD in
their research and development process. This has led to groundbreaking applications
in various fields in engineering and medicine and has eased the legal process for med-
ical system approvals. The CFD implementation has increased within the last years
among experts in medical, environmental, agricultural, and many other industrial
applications. It is crucial to have the fundamental knowledge of fluid mechanics to
make an appropriate initial assumption to simulate the phenomena correctly or, if
possible, make a user-friendly interface. For example, if we narrow down our atten-
tion to medical science and use CFD tools in clinical decisions, we need to tune the
output for each specific case. Although the CFD application is growing every day,
major challenges exist, such as computational speed, mathematical modeling defects,
computer power limits, etc. In this dissertation, we are going to study two applica-
tions of Computational Fluid Dynamics (CFD) in Biomedical Engineering. In the
first application, we are going to study drug delivery in the posterior eye. This study
involves the computational solving of the non-linear Navier-Stokes equations and the
mass diffusion equation. At the second application, we will use the volumetric lattice
Boltzmann method (VLBM) to compute wall-shear stress and velocity distribution
inside a rectangular duct.
21.1 Computational Fluid Dynamics (CFD)
The fundamental equations that describe the motion of the flow are Navier-Stokes
(NS) equations. Due to the highly non-linear structure of these equations, it is diffi-
cult to find an analytical solution. To this day, an analytical solution for NS equations
remains an open problem to solve. Another way to solve the NS equations is with
numerical methods. However, the numerical solution of these equations requires a
large number of iterations and is massively time-consuming. The conventional ap-
proach to solve NS equations is the Direct Numerical Solution (DNS). This method
is generally considered the most straightforward method in Computational Fluid Dy-
namics. However, this method requires a large memory and is slow compared to other
methods, such as the Lattice-Boltzmann Method (LBM). The computational cost for
this method is high, even at low Reynolds numbers. In most industrial applications,
DNS cannot be used even within the means of most powerful computers to this day.
However, there are applications for this method at small Reynolds numbers, and there
are many cases that we need to use DNS. The applicability of DNS is usually limited
to low to moderate Reynolds numbers. There are other numerical methods for higher
Reynolds numbers than can capture more details in simulation, such as Reynolds
averaged Navier-Stokes (RANS) or Large Eddy Simulation (LES), which is excluded
from the content of this thesis.
1.2 Objective
In this dissertation, we explore two different applications of computational fluid
dynamics in Bio-engineering. At the first application, we present a new computa-
tional model by introducing a porous separator (or divider) within the drug storage
(implant) and simulate the drug delivery to the posterior eye. The research objec-
tive is to avoid the overshooting of drug concentration at initial times and increase
the average concentration at every time point. This can be done by changing the im-
plant internal structure. The computational model focuses on the eye posterior layers
3(sclera, choroid, and retina). We first validate our computational model by repeating
the results in [1]. Then, we systematically investigate how the porous structure in
the implant affects drug delivery. The second application aims to obtain an accurate
computational model to simulate the pulsatile flow inside a rectangular duct. By
getting a well-defining LBM model, we can proceed to use the computational code in
simulating wall shear stress and velocity field inside similar domains, such as pulsatile
flow over the bone cells. These results can be later used to research how the bone
cells respond to the wall shear stress [2].
42. COMPUTATIONAL MODELING OF INTRAOCULAR
DRUG DELIVERY SUPPLIED BY POROUS IMPLANTS
2.1 Introduction
Age-related macular degeneration (AMD) is a degenerative disease of the retina
layer where uncontrolled growth of cells in the blood vessels causes protein and blood
leakage and scars the macula (a part of the retina layer inside the eyeball). It is a
condition that often results in blurred or no vision in the central visual field. Such
vision loss is permanent, affecting people’s ability to recognize faces, drive or perform
daily activities. AMD is the leading cause of severe vision loss in people over age
sixty years old (The National Eye Institute 2020). According to the National Eye
Institute, as the elder population in the U.S. grows larger, more people are developing
eye diseases. In fact, from 2000 to 2010 the number of elderly people with AMD grew
18 percent, from 1.75 million to 2.07 million (The National Eye Institute 2020). It is
known that vascular endothelial growth factor (VEGF), a signal protein produced by
cells that stimulate the formation of blood vessels, is responsible for this eye disease
condition. Anti-VEGF drugs such as Ranibizumab, Macugen, and IgG1 Fab fragment
are frequently used to treat AMD. An injection is a common way to deliver drugs for
the treatment of AMD. However, this adds potential risks such as endophthalmitis,
hemorrhage, and retinal detachment [3], among others. The oral consumption of drugs
is an alternative but ineffective method to deliver the drug via blood flow. Since the
blood supply into the human eye is small, a large amount of drug consumption is
needed, which may put other non-diseased tissues in danger. Sclera permeability is a
less risky, less invasive, and more sustainable drug transport method of drug delivery
for AMD, enabling transscleral drug delivery [4]. In this type of drug delivery, an
implant that contains a drug is implanted on the posterior eye (AMD normally affects
5the posterior eye) and the drug diffuses into the eye slowly [5], providing a sustainable
drug transport source. The two goals of using the drug implant is to reduce the high
initial drug concentration in the eye, and to maintain a higher drug supply in later
periods of the treatment.
It is essential to predict drug transport in the different layers of the posterior
eye to design an effective delivery system. Drugs available for AMD have a narrow
therapeutic concentration window (i.e. limited range of drug dosages which can treat
the disease effectively without having toxic effects). Medication with such a restricted
therapeutic window must, therefore, be administered with care and control. High
drug concentrations can be harmful to the eye while low drug supply results in the
ineffective treatment of AMD [6]. Therefore, it is crucially important to determine
the time evolution of drug concentration in each layer in the posterior eye. There are
experimental techniques available to measure drug concentration in the eye such as
absorption spectroscopy [7] and direct sampling [8]. Some studies have emphasized
the benefits and challenges of such experiments. Miller et al. (2005) [9] have reported
minimally invasive and direct measurements of drug concentration in the eye via
absorption spectroscopy whereas Conrad and Robinson (1977) [8] have described that
direct sampling is possible but difficult for the patient.
Numerical simulation of drug delivery in the eye is a new and non-invasive method
to measure the time evolution of drug concentration. This technique offers several
advantages, including the ability to i) study a system or phenomenon at different
length and time scales, ii) obtain reliable results, once well validated by available
analytical and/or experimental data, iii) perform analysis of varied conditions, iv)
evaluate critical situations that can be investigated without risk, and v) carry out cost-
effective studies that can speed up so that system or phenomenon can be evaluated
over a long time. Simulations are usually much faster than experiments. In the present
study, we simulate 8-week drug delivery in less than 30 minutes with standard CPUs
of personal computers. Some of the disadvantages of simulations of drug delivery
in the eye include i) an understanding of the controlled drug delivery phenomena
6is needed as well as the associated limitations and approximations of the model to
discern the solutions from potential artifacts, and ii) limited experimental data [10] is
available regarding posterior eye layers. Several simulation studies have been reported
to date investigating the drug delivery in the eye computationally [11, 12], in which
drug delivery from a standard implant in the posterior eye is simulated using the finite
element method (FEM) and drug concentration evolution is calculated for different
eye layers. Other studies [13–15] have focused on computational modeling to simulate
the intravitreous drug injection in the human eye.
The thermally responsive hydrogel NIPAM has been used to evaluate ocular drug
delivery computationally [11,16] by placing it on the sclera close to the optical nerve.
Previous simulations of drug delivery from an episcleral (N-isopropyl acrylamide)
NIPAM-gel implant by [16] predicted sustained delivery times of eight weeks with
both 1.0 and 0.5 mg monthly doses using a compartmental model. Later, simulations
by [11], using a computational model of IgG1 Fab delivery from an episcleral NIPAM-
gel implant, released the drug at the same rate and monthly doses as in [16] in a new
model of the human eye to determine the time needed for sustained delivery. Results
from the latter study [11] show that the average drug concentration is at therapeutic
levels within all three layers in the posterior eye during the first eight weeks after drug
administration, similarly to those with intravitreal injection [15]. Kavaousanakis and
co-workers (2014) [11] concluded that delivery of the IgG1 Fab drug from an episcleral
NIPAM-gel implant seems to be an effective alternative to more invasive means of
delivery to the posterior eye by injection. Thus, we used these results in our validation
phase in this work. Since we need to keep the drug concentration in the desired
therapeutic range, it is imperative to use the proper amount of drug concentration.
It is noteworthy that we excluded the vitreous humor and confined our simulations
to the eye posterior layers (sclera, choroid, and retina) from a porous implant.
In this study, we present a new computational model of a drug storage (implant) in
which a porous separator (or divider) is introduced and simulate the drug delivery to
the posterior eye. The research objective is to achieve an appropriate time evolution
7of the drug concentration, avoiding the overshooting of drug concentration at initial
times and increasing the later concentration. This can be done by changing the
implant internal structure and including pores. We keep the drug concentration in the
desired therapeutic range. The computational model includes the eye posterior layers
(sclera, choroid, and retina) and drug storage. We first validate our computational
model by repeating the results in [11]. Then, we systematically investigate how the
porous structure in the implant affects drug delivery.
2.2 Computational Modeling and Governing Equations
To study the effects of implant structure on the drug delivery to the posterior
eye, we created a model representative of the human eye together with an implant
attached to the sclera layer on the back of the eye. Fig. 2.1.(a) illustrates a cross-
sectional view of a human eye. The vitreous humor is a gel-like porous medium, which
comprises most of the interior eye. It is enclosed by the retina layer on the posterior
eye and by the lens and hyaloid membrane on the front side of the eye.
2.2.1 Human eye representative and computational modeling
The front side of the eye, i.e. lens and pupil, were not be taken into account
in this study because they are almost impermeable to drugs as there is constant
flow drainage between the iris and lens which washes any drug away. Since the
transport of macromolecules such as IgG1 Fab is not significant in the front of the
eye (cannot penetrate the hyaloid membrane) and the drug for the AMD targets
the three posterior layers, the vitreous humor was not included in this study either.
Fig. 2.1.(b) shows the 2D computational model consisting of posterior layers (retina,
choroid, and sclera), and a drug storage implant with a porous structure. We used
COMSOL Multiphysics version 5.4 (COMSOL, Inc., Burlington, MA) to simulate the
delivery of IgG1 Fab drug from the porous implant to the posterior layers. The main
physical property values and dimensions were based on experimental data [11, 12],
8Fig. 2.1. Schematics of a cross-section of the human eye showing
an episcleral implant and key features. (a) An anatomical view
of the posterior segment consisting of three distinct layers (sclera,
choroid, and retina). (b) Computational geometry involving the pos-
terior layers (retina, choroid, and sclera) and a drug storage implant
with a porous separator (white and black squares mean solid pieces
and pores, respectively). Dimensions are to scale. Relevant dimen-
sions and properties are listed in Table 2.1. Figure (b) shows a two-
dimensional axisymmetric model of the eye and the axis of symmetry
is shown as the dashed line in Figure (b). The domains shown in the
figures are connected to each other and do not have separate boundary
condition
as summarized in Table 2.1. Boundary conditions were introduced as follows. The
pressure at the outer surface of the sclera layer, Ps (=1300 Pa) known as previously
reported [17]. The pressure at the hyaloid membrane is equal to the intraocular
pressure (retina layer), i.e. Ph (= 2000 Pa) [11].
The hyaloid membrane is a layer permeable to small drugs such as fluorescein but
impermeable to heavier drug molecules such as IgG1 Fab. There is no concentration
flux at the sclera and retina’s external walls and the implant’s walls, i.e., nˆ·∇c |wall= 0,
in which n is the normal vector to the surface, D is the diffusion coefficient, and c is
the drug concentration. The initial velocity is considered zero for the entire domain
as well as zero concentration of the drug. The supply of the drug concentration in
9the implant is given in Fig. 2.2.(b). The specific location of the drug supply will
be identified later. The numbers of mesh in the radial direction are 3 in the retina
and choroid layers and 4 in the sclera layer respectively. The number of mesh in the
tangential direction is 1400. The distribution of the mesh in each direction is uniform.
The convergence check is done for the considered mesh size.
The parameters used in the simulations for the transport of the IgG1 Fab fragment
are summarized in Table 2.1.
There are several approximations in this study that must be pointed at:
• The concentration distribution is considered uniform all along the implant-sclera
intersection
• The sclera, choroid and retina’s properties are considered uniform in all part of
them
• The hydrogel is considered to has a solid size and remain
• the experimental measurements are limited and more experiments are needed
in order to enhance the simulation results
• The assumed geometry for the eye is not perfect sphere, but for the case of
simplicity we have considered sphere in our simulation
• A three dimensional model would be more accurate in presenting the results
but we are using a two dimensional axisymmetric model
2.2.2 Mathematical model and governing equations
The flow domain including sclera, choroid, and retina layers in Fig. 2.1.(b), is
treated as a porous medium. The eye drug is stored in the implant and delivered to
the posterior layers. As the flow in the sclera, choroid and retina layers is weak, we
used the Darcy (creeping) flow equation. The creeping flow equation is coupled with
10
Table 2.1.
Physical property values for the posterior eye layers and implant in this study.
Parameter Value Source number
sclera (outer layer) - -
Hydraulic conductivity (µ/k)s 1.5× 10−11cm2/Pa.s [12, 18]
Thickness (ds) 0.6 mm [15]
Diffusivity (Ds) 4.596 ×10−7cm2/s [16]
choroid (middle layer) - -
Hydraulic conductivity (µ/k)c 1.5 ×10−11cm2/Pa.s [18]
Thickness (dc) 0.32 mm [15]
Diffiusivity (Dc) 3.616 x 10-8 cm2/s [16]
Drug elimination rate constant
(kec)
0.2398 day−1 [7]
retina (inner layer) - -
Hydraulic conductivity (µ/k)r 2.36 ×10−11cm2/Pa.s [19]
Thickness (dr) 0.22 mm [15]
Diffuisivity (Dr) 2.442 ×10−7cm2/s [16]
Drug elimination rate constant
(ker)
0.2063 day−1 [7]
Implant with Porous Separator - -
Diffiusivity (Di) 6.0 ×10−6cm2/s [20]
Rectangular Shape, radius 0.10 cm [11]
Rectangular Shape, width 0.70 mm n/a
Separator, width 0.045 mm n/a
Separator, pore size (d) 0.008-2.0 mm n/a
the diffusion equations to reflect the convective drug transfer. We, therefore, focused
on the diffusion and convection of IgG1 Fab drug doses to the posterior layers.
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Diffusion flow model for the IgG1 Fab drug
The porous media flow in the posterior layers is assumed to be incompressible,
and is governed by the following Darcy flow equation:
~v = −k
µ
×∇p (2.1)
where v, k, µ, and p are the flow velocity, the permeability of the medium, the
viscosity, and the pressure of the fluid respectively. The permeability term in Dracy’s
law depends on the domain that we are studying and is different at different eye
layers.
Diffusion-convection equations for the sclera, choroid, and retina layers
Drug diffusion through the layers of the posterior eye is modeled by the diffusion’s
First Law. As seen in Fig. 2.1.(b), the drug solution (IgG1 Fab) is released in the
gel implant and delivered to the posterior eye. Molecular diffusion is deemed the
main driving mechanism for drug transfer through the layers of the posterior eye.
For calculating the transport of the drug through the layers of the posterior eye,
we introduce the diffusion-convention equation in each layer of the posterior eye as
follows: sclera (outer) layer:
∂cs
∂t
+∇2c+ ~v · ∇c = 0 (2.2)
choroid (middle) layer:
∂cc
∂t
+∇2c+ ~v · ∇c = 0 (2.3)
retina (inner) layer:
∂cr
∂t
+∇2c+ ~v · ∇c = 0 (2.4)
In Eqs. (2)-(4), Ds, Dc, and Dr are the drug diffusivities in the sclera, choroid and
retina layers, respectively, and kec and ker are rate constants of drug elimination due
to the absorption to the veins in the choroid and retina, respectively. There is no
drug elimination in the sclera and thus there is no rate constant of drug elimination
in Eq. (2).
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2.3 Validation: Drug delivery via hydrogel implant
IgG1 Fab is a macromolecular anti-VEGF drug routinely used to treat AMD.
Experimental data on IgG1 Fab drug concentration in the layers of the posterior
eye for intravitreal (IVT) injection or delivery from a local implant is not currently
available. Clinical studies have shown that the therapeutic effects of drug doses of 0.5
and 1 mg/cm3, regularly delivered by IVT injection, extend for two months [17]. In
this section, we validate our simulation with independently reported data [11] for the
delivery of IgG1 Fab to the layers of the posterior eye using a hydrogel implant (Fig.
2.2.(a)). Then we simulate the episcleral delivery of IgG1 Fab drug to the layers of
the posterior eye via a new type of porous implant (Fig. 2.2(b)). The parameters
used in the simulations for the transport of the IgG1 Fab fragment are in Table 1.
To validate our computational modeling with previous experimental and compu-
tational studies [11,16], we placed the IgG1 Fab drug source on the left inner wall of a
hydrogel implant, as seen in Fig. 2.2.(a), to study drug delivery to the posterior layers.
On the implant inner wall, the drug concentration is set to decay exponentially for 2
days of release as seen in Fig. 2.2.(b). We focus on the drug delivery across the poste-
rior layers in terms of the time evolution of the drug concentration and drug delivery
velocity across the layers. Fig. 2.3.(a) shows the time evolution of the average IgG1
Fab drug concentration in the sclera (black), choroid (red), and retina (blue) layers
within two months after administration begins, for a monthly dose, Co = 1mg/cm
3.
Drug concentrations have been normalized with the therapeutic concentration value
of Ctherapeutic = 150 mg/cm3 [11]. This therapeutic concentration is the minimum
required concentration of the drug that must exist to have an effective treatment. The
corresponding solid symbols are computational results from a previous study [11]. Be-
cause of the very high amount of the initial drug concentration at the implant, there is
a high value of drug concentration at the beginning, in the three different layers (Fig.
2.3.(a)). By the time the drug source weakens and the drug absorption overpowers
the drug transfer from the implant, the concentration shows a decline. The velocity
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Fig. 2.2. The setup of IgG1 Fab drug in a hydrogel implant. Illustra-
tions show (a) the drug source is placed on the hydrogel implant-sclera
interface (black line) and (b) the exponential decay of the drug con-
centration at the implant when C(t = 0) = Co = 1mg/cm
3 [16]
profile along the choroid-sclera interface is shown in Fig. 2.3(b). The rapid change
of the velocity at the beginning and the end of the graph can be attributed to the
fact that there is a sharp pressure gradient between the outer surface of the sclera
and the hyaloid membrane and the measurement starts to close the intersection of
the sclera and the hyaloid membrane. The pressure gradient is uniform through the
rest of our arc because the distance between retina’s outer surface and sclera’s outer
surface remains the same. Overall, our simulation results agree well with the open
data (Kavousanakis et al. 2014).
2.4 Numerical Results and Discussion
In this section, we investigated the effects of implant setup and implant structure
on the drug delivery. We studied the role of drug source location on the concentration
levels calculated in the posterior eye layers. Then, we conducted simulations of the
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Fig. 2.3. Validation results regarding drug delivery to the posterior
layers. Calculations show (a) time evolution of the average IgG1 Fab
drug concentration in the sclera (black), choroid (red), and retina
(blue) layers respectively. Solid lines are the results of the current
simulations and solid squares are data from a previous study [11].
The velocity profile (b) along the choroid-sclera shows agreement with
prior findings by [11]. The solid line is from the current simulation
and the open squares are from reported open data reported by [11]
.
delivery of IgG1 Fab to the posterior layers using a porous implant. In this case,
we analyzed the effect of pore size on drug concentration evolution and compared
results against the former standard hydrogel implant. All these results and analysis
are described next.
2.4.1 Role of drug source location
The previous study placed the drug on the left inner wall of the implant, Fig.
2.4.(a), which has eliminated the functionality of the implant. Here we explore the
effect of drug source location in the implant on the drug delivery in the posterior
eye layers. Fig. 2.4. shows the time evolution of the IgG1 Fab drug concentration
in the three posterior layers using two different drug source locations in the implant:
(a) left wall and (b) right wall. It is evident from these results that the location
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of the drug source (i.e. concentration boundary condition) is important to consider
in the evolution of the mean drug concentration. Placing the drug source in the
sclera-implant interface (case (a)) was found to be more accurate when comparing
data against prior simulations [11] than the alternative (case (b)). This despite the
fact our implant dimensions are smaller than those reported before by [11] yet the
concentration levels and trends are similar as demonstrated in Fig. 2.4.(a). It is
reasonable to expect drug concentration levels in the eye layers to be higher in case
(a) than in case (b) - where drug transport will require more time to reach all three
layers and thus concentration levels will decrease. Note also that case (a) has an
enlarged sclera-implant interface (i.e. length of black line) compared to case (b) and
hence the higher values.
Furthermore, as seen in Fig. 2.4, the drug concentration curves show higher
peaks for case (a) than case (b) in all three layers. This can be attributed to the
fact that drug spreads into the eye faster than it gets eliminated, and concentration
peaks are higher since the drug source is closer to the eye layers or in “direct contact
with the sclera”. However, the drug source will change location (case (b)), for an
implant containing a porous separator as in Fig. 2.4.(a), which will essentially create
a diffusion barrier to drug transport and further slowdown drug diffusion.
2.4.2 Diffusion through porous implants: Pore size effect
The objective of the current research is to explore a new implant with porous
media structure that can efficiently control the drug delivery in the posterior eye.
In this study, we introduce a single separator in the implant to mimic the porosity
of a porous media structure, as seen in Fig. 2.5.(a), and study the effects of the
separator traits (i.e. pore size) on the drug delivery. The physical properties of
this implant are the same as the physical properties of the sclera (i.e. diffusion
coefficient and permeability). As shown in Fig. 2.2.(a), the drug is placed on the
right inner wall of the implant with the same concentration decay as in Fig. 2.2.(b).
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Fig. 2.4. Time evolution of the average IgG1 Fab drug concentration
in the sclera (black), choroid (red), and retina (blue) layers, during
the first two months after administration begins. The drug sources
are placed on the (a) left wall (case a) and (b) right wall (case b) of
the implant.
The pore arrangement is adjustable thus the drug release to the posterior layers can be
precisely controlled through the porosity of the porous media structure The concept
of introducing porous barriers (separators) within an implant is used in this study to
examine the effect of porosity on drug release. Since the drug source (concentration
boundary condition) is placed on the right side of the porous implant as in Fig.
2.5.(b), this allows the evaluation of pore sizes inside the implant for sustained drug
delivery in a systematic manner.
We have used different pore diameters in a separator inside a hydrogel implant
(Fig. 2.5.(a)) to examine their effect on drug concentration to the posterior eye lay-
ers. Clinical studies with IgG1 Fab, delivered by IVT injection, have reported that
17
Fig. 2.5. Illustration of the porous implant structure comprising of
a single separator with adjustable pore size. The diagrams show (a)
key dimensions of the implant and (b) implant position next to the
sclera, arrows indicating drug flow towards posterior layers. In this
study, the IgG1 Fab drug source location is placed on the right inner
wall of the implant.
the time during which the drug concentration in the choroid and retina layers is at
a therapeutic level is about 8 weeks. Fig. 2.6. summarizes the evolution of drug
concentration in each of the eye layers (sclera, choroid, and retina) as a function of
pore diameter during this period of interest. Drug concentrations have been normal-
ized with the therapeutic concentration (Ctherapeutic = 150µg/l = 150mg/cm
3), which
completely inhibits neovascularization. As Fig. 2.6. shows, the average drug concen-
trations in the sclera (a) remains higher at all times compared to those in the choroid
(b) and the retina (c). This can be attributed to the fact that the released drug in
the latter (b) and (c) has to pass through the implant and larger sclera, diffusing at a
lower speed into the eye due to differences in diffusivity values and drug elimination
rates. Results in Fig. 2.4. indicate that the average drug concentration levels in all
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Fig. 2.6. Average drug concentration in the (a) sclera, (b) choroid
and (c) retina using a porous implant, as a function of pore sizes as
shown in Fig. 2.6.(a), during the first two months after administration
begins and where co = 1mg/cm
3. Legend denotes pore size vary in
diameter d in case: 2, 0.2, 0.04 and 0.008 mm.
three layers are lower for the porous implant Fig. 2.4.(b) than those for the standard
hydrogel implant in Fig. 2.4.(a). The porous separator is essentially a barrier to drug
diffusion and thus drug concentration levels are expected to diminish. The trends
in Fig. 2.6. (a-c) show all drug concentration curves increase at the beginning until
they reach a maximum value (peak) before decreasing rapidly for all pore sizes. The
differences in drug concentrations in Fig. 2.6. (a-c) can be explained as follows. It
will likely take more time for the drug to diffuse through the porous implant (than
the standard implant) and reach all three layers, and given the different diffusivities
per layer, the average drug concentrations would be lower in each subsequent inner
layer (i.e. sclera > choroid > retina with the lowest drug concentrations) as seen in
Fig. 2.6. (a-c).
More significantly, results in Fig. 2.6. show that as pore size decreases in the
porous implant so do the average drug concentration levels in all three layers. Fig.
2.6. suggests a correlation between pore size and drug concentration, i.e. the smaller
the pore diameter is, the lower the average drug concentration is in each layer and vice
versa. The average drug concentration profiles reveal distinct peaks in the layers, in
particular in the sclera (Fig. 2.6.(a)). It is noteworthy that as pore diameter shrinks,
the drug diffuses through the porous implant into the sclera faster (Fig. 2.6.(a)).
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2.5 Conclusion
To study the effects of the implant structure on the drug delivery to the posterior
eye, we use a representative model of human eye together with an implant attaching
on the sclera layer on the back. Fig. 2.1.(b) shows the schematic of a cross-sectional
view of the posterior segment of a human eye (dimensions are not scaled). The
vitreous humor is a gel-like porous medium, which comprises most of the interior eye.
It is enclosed by the retina layer on the posterior eye and by the lens and hyaloid
membrane on the front side of the eye. The implant is attached to the posterior eye
close to the optic nerve and it is used to release the drug during an eye treatment.
The front side of the eye, i.e. lens and pupil, were not be taken into account because
they are almost impermeable to drugs as there is constant flow drainage between the
iris and the lens which washes any drug away, and thus can be eliminated.
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3. LATTICE BOLTZMANN METHOD AND WALL
SHEAR STRESS SIMULATION
3.1 Introduction to Lattice Boltzmann Method
In the past few decades, by the growth of computer powers, scientists have started
to use CFD more than ever. In thermo-fluid science, we generally have to deal with
phenomenons that consist of highly non-linear partial differential equations (PDEs).
A great example of such a comparison is the well-known Navier-Stokes equations. The
Navier-Stokes equations contain highly non-linear convective terms and are highly
coupled. To this day, there is no analytical solution for the general format of Navier-
Stokes equations. The analytical solution of NS is one of the great problems of the
century. The most popular way to deal with these equations is to use computational
methods. There are many ways developed to solve the Navier-Stokes equations nu-
merically. Perhaps the most famous routines in solving the NS equations (and also
the most fundamental) are the finite difference method (FDM) and finite volume
method (FVM). We use a set of rectangular grids in the finite difference method and
discrete the governing equations over those grids. In each cell, the cell’s information
is located in the middle. The governing equations are discretized over the cells and
solved numerically using the values at the center of the cell. The finite volume method
is a more complex, however, more accurate way. It uses the divergence theorem to
transform the volume integral of PDEs into the surface integral to transfer the flow
of information from each cell to another. The NS equations are derived with the
assumption of continuum macroscopic space. In recent years scientists have used a
different approach to solve the CFD problems called the lattice Boltzmann method
(LBM). The LBM has become a popular and alternate method in many CFD-related
fields, such as flow in porous media and heat transfer problems [21]. In this approach,
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we do not use the familiar Navier-Stokes equations. Instead, we change our sight to
the kinetic theory equations and use the distribution function to solve the kinetic
theory equations. Although LBM does not use the Navier-Stokes equations, we use
the macroscopic parameters similar in Navier-Stokes, such as velocity, density, and
pressure, to solve the field equations. Perhaps the most popular method in solving
the LBM is solving the lattice Boltzmann equations using the linear collision operator
provided by Bhatnagar–Gross–Krook [22].
The origins of the LBM returns to the lattice-gas-automata (LGA) [23]. In this
method, the lattice has n-dimensions and is regular; the gas takes the direction of
the lattice, and automata shows that the gas has to obey the collision process while
obeying a specific function. The problem with this method was the small natural
oscillations in the results, the dependence of the velocity to the pressure, and the large
dissipation in the numerical solution [24]. Later, by the means of a hexagonal lattice,
the Navier-Stokes equations were recovered. The problem of the noise oscillations was
solved later by the usage of the Boolean operator [25]. Higuera and Jimenez proposed
a linearized collision operator and assumed that the distribution function is close to
the equilibrium function locally [26].
The linearized collision operator Bhatnagar–Gross–Krook (BGK) has been used
more frequently by researchers and perhaps is the most famous one. In this collision
operator, boundary conditions play an essential role. The boundary condition is
different from the well-known boundary conditions that we use in the finite volume
method in CFD. In lattice Boltzmann, we deal with the collision of the particles, and
the fact that the boundary conditions are determined based on the collisions. The
bounce-back boundary condition is famous in LBM. Its origins get back to the LGA
and is used in most of LBM simulations. We will explore this in the kinetic theory
and mention why this boundary condition is used in section 3.1.1. In this boundary
condition, the distribution function before and after the collision has the opposite
direction.
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It is crucial to be able to recover the Navier-Stokes equations from the Boltz-
mann equations, and indeed there have been many types of research conducted to
obtain the relation between lattice Boltzmann equations (LBE) and Navier-Stokes
(NS) equations [27–30]. The LBE uses the collision operator to describe the inter-
action between the particles. One advantage of the LBE over the NS equations is
the gaseous flows [31]. LBE equations make it easier to study the gaseous flows in a
broader range of flow regimes. However, it is still uncommon to use the LBE equa-
tions in the study of the flows due to the complexity of the collision parameters and
the unfamiliar concept of kinetic theory between the researchers in fluid dynamics.
The common notation in LBM is as DxQy in which x stands for the dimensions
and y stands for the number of the velocity direction that particles have. For example,
D1Q2 shows a system with one dimension and two velocities vectors. It is fruitful to
point at some differences between Navier-Stokes equations and LBE:
• The Navier-Stokes equations use second-order partial differential equations, but
the kinetic equations used in LBM have the first order of magnitude accuracy.
• The convective term in Navier-Stokes equations are non-linear but the convec-
tive term in LBE is linear.
• The Navier-Stokes equation uses the iterative method, but the LBM method
does not.
• The boundary conditions in LBM studies the bounce back of the particles, while
in Navier-Stokes equations is about the macroscopic parameters. .
We will narrow down our focus to the incompressible fluids to simplify the mathemat-
ical procedure. The flow in biomedical engineering applications is highly considered
to be incompressible, therefore the incompressible flow assumption will not reduce the
accuracy of our model. Mach number is a useful parameter to draw a line between
compressible and incompressible fluid.
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Ma =
u0
cs
(3.1)
The u0 is the velocity of the fluid, and cs is the speed of the sound.
To maintain the incompressible fluid flow condition in our computation, we accept
the famous criteria for describing incompressible fluids:
Ma<0.3 (3.2)
The fluid dynamic can be sub-categorized into three levels [32]: (i) Molecular Dy-
namics: This considers each molecule’s motion. The position and velocity of each
molecule are studied in Molecular Dynamics. These systems contain a large num-
ber of molecules, and the behavior of the system can be studied by tracking every
molecule’s trajectory in the system. (ii) Kinetic Theory: which uses the means of sta-
tistical thermodynamics. It uses distribution functions to describe the system. (iii)
Hydrodynamics: studies the fluid structure at a macroscopic level. The individual
motion of each molecule is not an essential factor at this level, and the bulk motion
of the fluid is the only important issue in it. The conservation laws and continuum
fluid dynamic laws lay in this level. Parameters such as velocity (~u), density (ρ),
pressure (p), temperature (T) etc are measured in macroscopic level. These variables
represent the average behavior of a large number of molecules in an element. All
well-known equations such as Navier-Stokes equations, energy equation lay at this
level. The kinetic theory can be seen as a bridge between molecular dynamics and
hydrodynamics.
How to classify a system as one of the three mentioned systems? In order to study
a system of molecules, it is necessary to determine whether the motion of every single
molecule is essential or not. In a lot of cases, this can be assessed without much
effort. In studying a wind turbine, we usually use coarse approximations and analyze
a large volume of the system. In many cases, the problem requires us to consider small
volumes of fluid and, thus, a smaller number of molecules in the volume. There must
be a parameter to let us characterize the fluid in one of the mentioned categories.
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The Knudsen number, defined as Kn = λ/L, is a criteria for categorizing a system
of molecules. Here, L is the characteristic dimension of the system of particles, andλ
is the mean free path of the molecules. Continuum models based on NS equations and
Euler equations are generally valid when 5 ≥ Kn ≥ 0.01, but can be extended into
the slip-flow regime (0.1 ≥Kn ≥ 0.01) by appropriate treatment of the wall boundary.
However, the discrete particle model based on the Boltzmann equation governs almost
all the flow regimes (Kn ≤ 100). This implies the fact that Boltzmann equations can
cover a wide range of applications in fluid flow problems.
3.1.1 Kinetic theory
Although the fluid flow problems are generally described by Navier-Stokes equa-
tions and the rules of the continuum system, it indeed is formed from a large number
of molecules. Thus it can be described with kinetic theory. The fundamental assump-
tions in kinetic theory are:
• The mean free path of the molecule is much bigger than the molecule size.
• The system contains molecules that move incessantly with a distribution.
• The collisions between molecules are elastic and contain no exerted force.
• The Newtonian laws of motion are applicable.
According to the mentioned bullet-points, Newton’s laws are applied in kinetic
theory, and at the same time, we have a relatively large number of molecules. Thank-
fully we do not need to solve every single molecule equation of motion. We are using
the macroscopic parameters such as velocity, density, and temperature to represent
the average bulk behavior of molecules. The next step to study the system is to find
a distribution that describes these parameters the best.
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3.1.2 Boltzmann equation
Let’s assume xi(or~x) as the Cartesian coordinates of a physical space, and ξi(or~ξ)
the molecular velocity. Our goal is to determine a distribution function f(~x, ξ, t), for
the velocity in which determines the probability of finding a molecule with velocity ~xi,
at position ~x and time t. This distribution function is the key to find other parameters
such as ρ(~x, t) , the momentum density ~u(~x, t) , the internal energy density e(~x, t) ,
the stress tensor σ(~x, t) , and the heat flux vector ~q(~x, t) can be obtained by using
the following equations:
ρ(~x, t) =
∫
f(~x, ξ, t)d~ξ (3.3)
ρ~u(~x, t) =
∫
~ξf(~x, ξ, t)d~ξ (3.4)
ρe(~x, t) = 1/2
∫
~ξ0
2
f(~x, ξ, t)d~ξ (3.5)
σ(~x, t) = −
∫
~ξ0~ξ0f(~x, ξ, t)d~ξ (3.6)
~q(~x, t) = 1/2
∫
~ξ0(~ξ0 · ~ξ0)f(~x, ξ, t)d~ξ (3.7)
Where ~ξ0 = ~ξ − ~u, is the molecule velocity respect to the bulk velocity of the flow.
One of the principles in kinetic theory gives us the following relation between energy
density and temperature:
e =
D0
2RT
=
D0
(2m)kBT
(3.8)
where D0 is the degree of freedom of each molecule, and m is the mass of a single
molecule. R and kB are the ideal gas constant and Boltzmann constant, respectively.
The degree of freedom coefficient depends on the number of atoms in the molecule.
For multi-atomic molecules, it is indeed a challenge to find this coefficient, but for
this case, we are going to study the single-atomic gas molecules in which D0 = 3.
The governing equations of the kinetic theory are all a product of the distribution
function f(~x, ξ, t). The famous lattice Boltzmann equation is:
∂f
∂t
+ ξi
∂f
∂xi
= J(f) (3.9)
26
Where J(f) is a function that describes the distribution function change due to
the collisions. As it was mentioned, the collisions are elastic and conservative and
can be shown as: ∫
d~ξJ(f)

1
~ξ
ξ2
 = 0 (3.10)
3.1.3 Collision term and its property
The first step to solve the equation 3.9 is to derive an equation for the collision
parameter J(f). To get an expression about the collision parameter, we are going to
take the following assumptions:
• We only take into account the binary collision.
• The collisions happen in a short range.
The other assumption is the Boltzmann gas limit [33]:
N −→∞
m −→ 0
ν −→ 0
Nσ2 −→ constant
Nm −→ constant
In which N is the total number of molecules, m is the molecular weight and the
ν is a characteristic force length. We finally can get the collision function as [34]:
J(f) =
1
m
∫
dSd~ξ1 | ~ξ1 − ~ξ | (f ′f ′1 − ff1) (3.11)
In which dS is the cross section of the collision. ~ξ′ and ~ξ′1 are the velocities of
the molecules before the collision, and ~ξ and ~ξ1 are the molecular velocities after the
collision.
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We can show the collision formula in another format. It is shown that the collision
term can be rearranged in the following form due to the symmetrical behavior [34].
∫
d~ξJ(f)ψ(~ξ) =
1
m
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ) (3.12)
In which ψ(~ξ) is a function of ~ξ. We can simply replace the ~ξ in ψ(~ξ) with ~ξ1 on
the right hand side of the equation:
∫
d~ξJ(f)ψ(~ξ) =
1
m
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ1) (3.13)
By substituting the variables ~ξ′ and ~ξ′1 with variables ~ξ, ~ξ1 and some mathematical
simplifications, we can transform ~ξ, ~ξ1 to ~ξ′ and ~ξ′1:∫
d~ξJ(f)ψ(~ξ) = − 1
m
∫
dSd~ξ′1d~ξ′ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ′) =
− 1
m
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ′)
(3.14)
Similarly, ∫
d~ξJ(f)ψ(~ξ) = − 1
m
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ′1) (3.15)
By using the 3.14 and 3.15 the new combination would be:
∫
d~ξJ(f)ψ(~ξ) = − 1
4m
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | [ψ(~ξ) + ψ(~ξ1)− ψ(~ξ′)− ψ(~ξ′1)] =
1
4
∫
d~ξ1d~ξJ(f)[ψ(~ξ) + ψ(~ξ1)− ψ(~ξ′)− ψ(~ξ′1)]
(3.16)
We can use this equation to obtain a new form of the collision equation as:
∫
d~ξJ(f)

1
~ξ
ξ2
 = 14
∫
d~ξJ(f)

1 + 1− 1− 1
~ξ + ~ξ1 − ~ξ′ − ~ξ′1
ξ2 + ξ21 − ξ′2 − ξ′12
 = 0 (3.17)
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These are a set of three individual equations: The conservation of mass, the conserva-
tion of momentum, and the conservation of energy, respectively. The zero value at the
right-hand side of the equation implies the fact that our equations are conservative.
We formerly have assumed that the collisions are between two particles. It means
that if ψ(~ξ) equals to one, then in a binary collision, ξ, and ξ2 corresponding to mass
density, momentum, and energy density.
3.1.4 H-theorem and Equilibrium equations
All the isolated system will finally meet the equilibrium if they are given enough
time. Consider the H function as the following:
H(~x, t) =
∫
f ln fd~ξ (3.18)
by taking a derivative from equation 3.18 we have:
∂H
∂t
=
∫
(1 + ln f)
∂f
∂t
d~ξ (3.19)
If we only consider a spatially uniform system, i.e., f depends on t only, the above
equation can be written as:
∂H
∂t
=
∫
(1 + ln f)J(f)d~ξ (3.20)
we assume that the f only is a function of t; therefore, the equation can be written
as:
∂H
∂t
=
∫
dSd~ξ1d~ξ | ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ′) ln(
ff1
f ′f ′1
)(3.21)
With the combination of the Boltzmann equation and the collision operator. Since
| ~ξ1 − ~ξ | (f ′f ′1 − ff1)ψ(~ξ′) ln(
ff1
f ′f ′1
)<0 (3.22)
and all the other terms in the above equation are positive, as a result:
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∂H
∂t
<0 (3.23)
The slope of this function is always less than zero, which tells us that the H function
always decreases with time. This is known as the Boltzmann’s H-theorem. As it was
mentioned, the studied H-theorem is only a function of t. The reader can refer to [33]
for more information about the non-uniform systems. By combining the equations
3.19 and 3.23 we can obtain a new form of equation for the equilibrium:
ff1 = f
′f ′1 (3.24)
By taking a logarithm from the equation 3.24 we have another form as:
ln f + ln f1 = ln f
′ + ln f ′1 (3.25)
we can conclude that the previous equation can lead us to the following expression:
ln fM(~ξ) = A+ ~B · ξ + Cξ2 (3.26)
The five constants A,B1, B2, B3, and C above are not arbitrary since we have an
equal number of constraints relating the first five moments given in Eqs. 3.3-3.7. The
resulting unique value of f obtained for the equilibrium state is:
fM(~ξ) = (
ρ
2piRT 3/2
)e−(~ξ − ~u)2/2RT (3.27)
which is the well-known Maxwell-Boltzmann equation.
3.1.5 Moments equations
We can integrate equation 3.9 with respect to velocity ψ and obtain the moment
equations. The results will be the conservation of mass and momentum and the con-
servation of energy equations. By taking the zeroth-order moment of the Boltzmann
equation, we have:
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∂
∂t
∫
fd~ξ +∇ ·
∫
~ξfd~ξ =
∫
J(f)d~ξ = 0 (3.28)
which gives us:
∂ρ
∂t
+∇ · (ρ~u) = 0 (3.29)
Which is the famous continuity equation. Using equation 3.9, the first-order moment
of the Boltzmann equation is:
∂
∂t
∫
~ξfd~ξ +∇ ·
∫
~ξ~ξfd~ξ =
∫
~ξJ(f)d~ξ = 0 (3.30)
The term
∫
~ξ0fd~ξ = 0 and therefore, we can write the LHS of the equation as
follows:
∇ ·
∫
(~ξ0 + ~u)(~ξ0 + ~u)fd~ξ = ∇ · [ρ(~u~u) +
∫
~ξ0~ξ0fdξ] (3.31)
By substituting equation 3.31 into equation 3.28, we obtain:
∂~u
∂t
= −(~u · ∇)~u− 1
ρ
∇ ·
∫
~ξ0~ξ0fd~ξ (3.32)
Which is the famous momentum or Navier-Stokes equation. The second order of
moment equation is:
1
2
∂
∂t
∫
ξ2fd~ξ +
1
2
∇ ·
∫
(ξ)2~ξfd~ξ =
1
2
∫
ξ2J(f)d~ξ = 0 (3.33)
we can simplify the left term of the LHS of equation as following:
∂
∂t
(
1
2
∫
(~ξ0 + ~u)
2fd~ξ) =
∂
∂t
[
∫
ξ2 + u2)fd~ξ] =
∂
∂t
(
1
2
ρu2 + ρ) (3.34)
and the second term can be extended as:
∇ · 1
2
∫
(~ξ0 + ~u)
2(~ξ0 + ~u)fd~ξ = ∇ · [ρ~u(1
2
u2 + ) + ~u ·
∫
~ξ0~ξ0fdξ +
1
2
∫
~ξ0ξ
2
0d
~ξ]
Thus we can rewrite the final equation as:
∂
∂t
= −~u · ∇− 1
ρ
[∇ · (~u ·
∫
~ξ0~ξ0fd~ξ − ~u · ∇ ·
∫
~ξ0~ξ0fd~ξ)]− 1
ρ
∫
1
2
ξ20
~ξ0fd~ξ (3.36)
and by knowing the fact that  = 3RT/2,
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3.1.6 Single relaxation time and BGK model
The frequent used collision parameter in LBM is the model given by Bhatnager,
Gross, and Krook (BGK) [35]. The collision term in this method is:
J(f) = −Z(f − fM) (3.37)
where fM is called the Maxwellian distribution function and Z is the mean collision
frequency. We can write a new form of Boltzmann equation by substituting the
collision term as:
∂f
∂t
+ ξi
∂f
∂ξi
= −Z(f − fM) (3.38)
which is the lattice Boltzmann equation with BGK collision parameter. by using the
Taylor series to expand the equation to the first order of magnitude 3.38 we will have
the following form:
f(~x+ ~ξ∆t, ~ξ, t+ ∆T ) =
1
τ
[f(~x, ~ξ, t)− fM(~x, ~ξ, t)] (3.39)
In which τ = 1
Z∆t
is the relaxation time and ∆t is the time step. we go further and
discrete the equation in phase space and consider the low Mach number assumption for
the problem in which leads to the single-relaxation time lattice Boltzmann equation:
fα(~x+ ~eα∆t, t+ ∆t)− fα(~x, ~eαt, t) = 1
τ
[fα(~x, ~eαt, t)− f eqα (~x, ~eαt, t) (3.40)
f eqα (~x, ~eαt, t) is the equilibrium function and the eα is the lattice velocity. The only
drawback with the BGK lattice Boltzmann collision operator is that it is valid for
small Knudsen numbers (kn0.1). We can use more sophisticated collision operations
to be able to deal with larger Knudsen numbers.
3.1.7 Volumetric lattice Boltzmann method
As we have mentioned, the LBM uses kinetic theory, and the kinetic theory’s
discrete equations are solved over time. The LBM method is a unique representation
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of discretized Navier-Stokes equations up to the second of accuracy [20, 36]. In a
conventional LBM method, everything is node-based. The particles are located at
the lattice nodes. As time goes by, these particles collide with each other and stream
to the nearby nodes toward their velocity directions. One celebrated LBE with the
collision operator provided by Bhatnagar-Gross-Krook (BGK) can be written as [37]:
fi(~x+ ~ei∆t, t+ ∆t) = fi(~x, t) + Ωi(~x, t) (3.41)
Ωi(~x, t) = −fi(~x, t)− fi(~x, t)
eq
τ
(3.42)
In which ~ei is the velocity of the particle in the ith direction, and is called the
relaxation time. Generally, the bounce-back boundary condition works fine for many
fluid flow problems in which the boundary is motionless. The scheme for moving
boundary has been provided by [38]. In this method, the wall’s velocity and its
effect in studying the bounce-back of particles is also introduced. More sophisticated
methods have been provided using the interpolation/extrapolation of velocity for
complicated geometries and moving boundaries. Many of these methods do not deal
well with the conservation of mass and momentum. This defect can cause further
problems in balancing the particle distribution, and for complex geometries, this can
lead to wrong results. Moreover, the usage of higher-order interpolation/extrapolation
can cause a huge computational cost and at the same time is hard to implement.
Aidun et. al. have come up with a method in which the mass transfer at the boundary
is zero, but it also comes with its drawbacks [39]. One other way to meet the no-
slip boundary condition at the wall is the diffusive bounce-back criteria [40]. In this
scheme, we define a permeable boundary while applying the simple bounce-back of
the particles. This method has gained high success in its accuracy in calculating a
wide range of Reynolds numbers. Although all these progress has helped treat the
boundary condition in LBM simulations, the major drawback is yet the interpolations
at the boundaries. The interpolation increases the complexities of the problem and
increases the computational cost dramatically and is especially hard to study moving
boundaries.
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The volumetric lattice Boltzmann method has originated from studying the mov-
ing boundaries [41]. In this method, we have an equal number of particles at each
complete cell. At the boundary in which the solid wall cuts through the cell, the
number of particles can vary. The amount of the solid wall that occupies the cell
plays a vital role in this method. This can vary from zero (not occupied by the
solid wall) to one (total solid space). One great advantage of the volumetric lattice
Boltzmann method (VLBM) is that we can avoid using interpolations in the compu-
tations [37]. Several studies have been conducted to implement to increase the usage
of a volumetric approach in LBM for complex boundaries. One efficient method. [42]
used a cell-based velocity gradient revision and implemented bounce-back bound-
ary conditions and could successfully simulate the flow in cylindrical geometry for
below-average Reynolds numbers. They later provided a general VLBM algorithm
and verified it [43]. Yu et. al. [44] have used the P-value parameter to show the ratio
between the fluid and solid region. The equations in VLBM are derived based on the
P-value parameter and will be used in this dissertation. We use the Pv to represent
the P-value in the equations.
Fig. 3.1. The rectangular duct and attached coordination on it
34
The mathematical formulation for VLBM is almost the same for ordinary LBM
equations. The only difference is the introduction of P-value into the equations. In
the traditional LBM, the particles are located at lattice nodes, the same as Fig.3.2.(a)
and can move toward the shown directions. For the VLBM, the particles are sitting
at the lattice cells, as shown in Fig. 3.2.(b)
The function ni(~x, t) is the distribution of the particles that have the velocity ~ξi
with the coordinate of ~x and at time t. Same as the ordinary LBM method, we can
write the following equation:
ni(~x+ ~ξ∆t, t+ ∆t) = ni(~x, t) + Ωi(~x, t) (3.43)
In which Ωi(~x, t) is the described collision term. As we have mentioned, the
boundary cells play an important role in the formulation of VLBM. It is important
to have a mathematical
Fig. 3.2. The comparison of the node-based lattice and volume-based
lattice in a D2Q9 setup.
representation of the P-value in order to use in VLBM. Consider ∆Vf as the
volume of the fluid in a cell. We can use the amount of Pv to calculate the ∆Vf for
every cell.
∆Vf = (1− Pv(~x))∆V (3.44)
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Where ∆V is the volume of each cell. In the lattice unit, this volume equals unity.
There is a slight difference between the particle density distribution in the conven-
tional LBM fi and VLBM ni. They can be related with the help of fluid volume
as:
fi(~x, t) = ni(~x, t)/∆Vf (~x, t) (3.45)
By using the BGK model and single time relaxation, we would have the following
equation for the collision parameter:
Ωi(~x, t) = −1
τ
[ni(~x, t)− neqi (~x, t)] (3.46)
In which the particle distribution function can be written as:
neqi (~x, t) = Nωi[1 +
~ξi · U
c2s
+
(~ξi · ~U)2
2c4s
−
~U · ~U
2c2s
] (3.47)
In which the particle distribution function can be written as:where N is the number
of the particles at each lattice cell:
N(~x, t) =
∑
i
ni(~x, t) (3.48)
ωi is the weight assigned to the velocity in the ith direction and cs si the speed of
sound. The equations for density, velocity, and pressure are:
ρ(~x, t) =
∑ ni(~x, t)
1− Pv(~x, t) (3.49)
~u(~x, t) =
∑
ξini(~x, t)∑
ni(~x, t)
(3.50)
p(~x, t)− p0 = c2s[ρ(~x, t)− ρ0] (3.51)
In which ρ0 and p0 are reference densities and pressures.
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3.2 Study of Wall Shear Stress in pulsatile flows
3.2.1 Introduction to pulsatile flow
Pulsatile flow or Womersley flow is a flow that has periodic variation in its velocity
profile. The most popular type of these flows is cardiovascular flows. This type of
flow can also be found in other systems, such as car engines. Womersley first studied
this flow in his work about blood flow in the cardiovascular system.
Pulsatile flow has been proven to stimulate the bone cells by its induced wall
shear stress. However, this interaction was left relatively unnoticed by scientists at
the time. It is essential to obtain kinetic properties of the pulsatile flow over the bone
cell to have a better understanding of the possible method of the response of the bone
cell to the wall shear stress and velocity field. In this dissertation, we will investigate
one particular case of pulsatile flow over the bone cell. The physical properties of the
problem are taken from the Biomedical Engineering Department of Purdue School of
Engineering and Technology. In the first step, we will validate our model and use it
to simulate the blood flow over the cell. Oscillatory flow is a subcategory of pulsatile
flow. In this study, we are going to use the oscillatory blood flow for simplicity to
simulate the blood flow over the cell. .
3.2.2 Analytical solution and computational validation
In this dissertation, we are going to simulate the oscillatory blood flow over the
bone cell. We will use geometry with the dimensions of the physical problem and
use the lattice Boltzmann method in the simulation of wall shear stress and velocity
field around the cell. This lattice Boltzmann code was developed by the research
team of Professor Whitney Yu at the mechanical and energy engineering department
at Indiana University-Purdue University Indianapolis. This code computationally
solves the lattice Boltzmann equations in the GPU, and most programming has been
done on GPU In this section, we need to use the analytical solution as an accurate and
37
reliable answer to check our code’s validity. As was mentioned before, the considered
geometry for the blood flow in a rectangular duct. Several studies have investigated
the analytical solution of oscillatory flow in a rectangular cross-section: The Navier-
Stokes equation for rectangular duct is:
ρ
∂w
∂t
− µ(∂
2w
∂y2
+
∂2w
∂x2
) =
∂p
∂z
(t) (3.52)
Fig. 3.3. The rectangular duct and attached coordination on it
In which ρ is the density of the flow, w is the velocity of the fluid in the Z
direction, µ is the viscosity of the fluid, x and y are the locations in X and Y
directions, respectively and ∂p
∂z
(t) is the pulsatile pressure gradient in the duct which
is the function of time (t). Since the flow is the simple oscillatory flow, the pressure
gradient can be written as:
∂p
∂z
(t) =
dp
dz
sin(ωt+ φ) (3.53)
In which dp
dz
is the pressure gradient amplitude (constant), ω is the angular oscil-
lation speed of flow, and φ is the phase of the flow and can be determined from the
boundary condition of the fluid. The equation (1) can be non-dimensionalized as the
following equation:
β2
∂w¯
∂t¯
= eit¯ + (
∂2w¯
∂x¯2
+
∂2w¯
∂y¯2
) (3.54)
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β = b(ω/ν)0.5 (3.55)
x¯ =
x
b
(3.56)
y¯ =
y
b
(3.57)
t¯ = tω (3.58)
λ =
a
b
(3.59)
w¯ =
w
Pb2
ν (3.60)
β = b(ω/ν)0.5 (3.61)
In which β is called the reduced frequency, w¯ is the non-dimensional velocity, t¯ is the
non-dimensional time, Re is the Reynolds number, x¯ is the non-dimensional distance
inX direction and y¯ is non-dimensional distance in Y direction the solution is assumed
to have one steady and periodic component:
w¯(x¯, y¯, t¯) = W¯ (x¯, y¯)eit¯ (3.62)
With this assumption, the analytical solution for this problem will be:
W¯ (x¯, y¯) =
4
pi
∞∑
n=0
(−1)n
(2n+ 1)p2
(1 +
1
sin(D · λ)
[e
D
2
x¯ sinh(−D
2
λ)− e−D2 x¯ sinh(D
2
λ)]) cos(
2n+ 1
2
piy¯)
(3.63)
p2 = iβ2 + (
2n+ 1
2
pi)2 (3.64)
D = 2p (3.65)
Now we have the velocity distribution in the rectangular duct, so it is easy to calculate
the wall shear stress inside the duct. By taking the derivative with respect to the y
from the velocity equation, we would have:
τ =
4b2
pi
dp
dz
∞∑
n=1
(−1)n
(2n+ 1)p2
[1 +
1
sinh(D · λ) [e
D
2
x¯sinh(−Dλ
2
)− e−D2 x¯sinh(Dλ
2
)]]
×− sin(2n+ 1
2
piy¯)
2n+ 1
2
pi
b
(3.66)
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Which is the wall shear stress over the wall in a rectangular channel. Using the
Navier-Stokes equation, we can obtain the velocity profile equation for the oscillating
flow between two parallel plates as [45]:
u(y, t) = −1
ρ
dp
dz
eiωt
iω
[1− cosh(y
√
iω/ν)
cosh(b
√
iω/ν)
] (3.67)
by taking the derivative with respect to y, we can obtain the wall shear stress on the
wall over time:
τ = ν
dp
dz
eiωt
iω
[
sinh(y
√
iω/ν)
cosh(b
√
iω/ν)
]
√
iω/ν (3.68)
3.2.3 Mechanical properties of the problem
This data is provided by the Department of Biomedical Engineering research team.
To start the simulation, we need to know all the geometrical and physical parameters.
The assumed for the flow is a rectangular duct. Since the flow is fully developed in
most of its way through the duct, we only focus on the solution of the problem in the
X − Y plane. The geometry sizes are given in Fig. 3.5., and the physical parameters
are given in Table 3.1.
3.2.4 The transformation of volume the flow rate to the pressure gradient
We obtained the analytical solution in section 3.2.2, but to use the data given in
section 3.6.2. we need to extract the maximum pressure gradient from the average
flow rate. The pure oscillatory nature of the flow is essential in our calculation. The
relationship between the maximum pressure gradient and the average flow rate is:
dP
dz
=
1
T
∫
dp
dz
sin (ωt)dt = 2
∫
dp
dz
sin (2pit)dt = 7886Pa/s (3.69)
dP
dz
=
12µQ
bh3
= 5021.3Pa/s (3.70)
dp
dz
= 7887Pa/s (3.71)
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Table 3.1.
Physical property of the system
The maximum speed of the flow 0.1228 m/s
density of the blood 1000 kg/m3
blood kinematic viscosity 0.72× 10−6m2/s
volume flow rate 0.59× 10−6m3/s
angular oscillation speed of flow (ω) 2pi
width of the duct (2a) 37.6mm
volume flow rate 0.59× 10−6m3/s
height of the duct (2b) 0.3mm
In which dP
dz
is the amplitude of the pressure.
3.2.5 Transforming the STL file to P-value data
To import geometry in our code, we need to transform the geometry into a matrix
of P-values. The amount of P-value for the solid part of the geometry equals one,
and the fluid portion of the geometry equals zero. The P-value is between Zero
and One for the boundary cell in which the wall can pass the cell at any angle and
direction. The Solidworks software has been used in this dissertation to model. The
produced geometry will later be transformed into P-value data. This is done by the
STL2Pvalue code, which has been developed in the research team of Dr. Whitney Yu
at the mechanical and energy engineering of Indiana University-Purdue University,
Indianapolis. This code takes the STL format of the designed CAD and transforms it
into a P-value matrix that can be used as an input in our code. This code reads the
CAD, and based on the desired resolution that we order, it produces a mesh, and for
every single cell of that mesh, we get the following information about the geometry:
• Column one: the P-value
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• Column two: if the cell is a boundary cell the normal vector of the surface in
the cell in the X direction.
• Column three: if the cell is a boundary cell the normal vector of the surface in
the cell in the Y direction.
• Column four: if the cell is a boundary cell the normal vector of the surface in
the cell in the Z direction.
• Column five: if the cell is a boundary cell it gives the distance of the center of
the cell from the surface.
The output file of the STL2Pvalue code also contains information about the mesh
resolution in each direction. To verify the accuracy of the transformed geometry to
P-value data, use the volume comparison. The volume of the geometry is known, and
the dimensions were given in the CAD software. The goal is to compare this volume
with the volume calculated from the P-value data. To make the comparison, we have
started designing a cubic geometry with a sphere centered inside it.
If we sum the amount of P-value for all the cells in the entire domain, we will
obtain the solid volume of the space, which in this problem is the volume of the
sphere. Considering that each cell that is entirely inside the sphere has the P-value
equal to one, the summation of P-values inside the sphere gives the number of the
cells inside the sphere. By having the total number of the cells in the domain and
dividing the number of the cells inside the sphere to the total number of the cells, we
can get the volumetric ratio of the sphere to the cube. This volumetric ratio can be
easily be obtained from the dimensions given to the geometry and be compared to
the P-value results.
ΣPvalue
Number of the cells
=
ΣfluidPvalue+ ΣsolidPvalue
Number of the cells
(3.72)
The summation of P-values for the fluid part is zero, therefore we can simplify equa-
tion (3.70) as:
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Fig. 3.4. The rectangular cube and the internal sphere inside it. We
have chosen P-value equal to one for the spherical structure inside the
sphere, and P-value equals zero for the rest of the domain out of the
sphere and inside the cube.
=
ΣsolidPvalue
Number of the cells
=
volume of the solid sphere
volume of the cube
(3.73)
The Table 3.2. shows the accuracy of is this code against the number of cells.
Table 3.2.
Mesh resolution check
Mesh resolution percentage of error(%)
24*24*24 2.1
32*32*32 0.77
49*49*49 0.45
70*70*70 0.41
82*82*82 0.45
99*99*99 0.40
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The next step after confirming the accuracy of the imported geometry is validating
the LBM code. The validation has been done for the centerline velocity, and the wall
shear stress at the lower wall’s center. Keep in mind that this is not the optimum
mesh to get the best result for the computational calculation, but it tells you that
what number of mesh we need to represent the designed geometry with the least
amount of error.
3.2.6 Geometry and boundary condition
The dimensions of the problem are taken from the biomedical engineering depart-
ment of Indiana University-Purdue University Indianapolis. The dimensions and flow
direction are shown in the following figure.
Fig. 3.5. The rectangular duct used for the validation of the LBM code.
As you can see from the dimensions, the width of the geometry (b) is about 1000
times larger than the height of the geometry (h). The Length of the geometry (L) is
also around 2000 times larger than the height (h). If we use any coarse or fine mesh
to cover the side (h), we use many cells. Thus we need to use a smaller geometry that
represents the mechanical properties of the main problem. If we choose one percent
as the limit in error in center-line velocity and the wall shear stress, we will have the
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cross-section, as shown in Fig. 3.6. Moreover, the pressure gradient has also been
obtained from section 3.6.3. The actual problem contains the information about the
volume flow rate, but because the used parameter in the computational code is the
pressure gradient, we focus on the pressure gradient behavior, and its graph is as
shown in Fig. 3.7.
Fig. 3.6. The rectangular duct used for the validation of the LBM code.
3.2.7 Mesh and time step check
The next part of making sure about the validity of our code is the mesh resolution.
The optimal mesh size has been chosen regarding Table 3.3. of the results. This tells
Table 3.3.
Mesh resolution check for computation
Mesh resolution (h*b*L) percentage of error(%)
10*30*30 1.6
20*60*60 0.6
30*90*90 <0.1
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Fig. 3.7. The pressure gradient variation inside the rectangular duct.
us the appropriate number of mesh cells for our geometry is 30*90*90.
Table 3.4.
Time step resolution check
Time step (second) percentage of error(%)
1/500 1.7
1/1000 0.4
1/1500 <0.1
3.2.8 Wall shear stress calculation
Although the case of the validation is a simple duct with parallel walls and we
can simply discrete the equations over it, this is not always the case. There are
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many circumstances in which we encounter a geometry with a complex surface. The
problem with these surfaces is that the computational cells are not necessarily aligned
with the normal vector of the surface and so we cannot simply compute the wall shear
stress along the normal vector. Instead of using the velocity field and discrediting
it, we will calculate the strain rate and wall shear stress directly from the lattice
Boltzmann equation. The strain rate equation, according to LBM formula, will be:
Sαβ = − 1
2ρτc2s
∑
i
eiαeiβ(fi − f eqi )
= − 3
2Nτ
Σieiαeiβ(ni − neqi )
(3.74)
In which N is the number of particles in the cell, eiα and eiβ represent the particle
streaming directions. The shear stress is:
σαβ = 2µSαβ
The viscosity equation in lattice Boltzmann can also be calculated like:
µ = νρ =
1
3
(τ − 1
2
) (3.76)
In which ρ is the lattice density and equals to one. Total stress can be calculated
from the following equation:
Tαβ = −pδαβ + σαβ (3.77)
In which δαβ is the Kronecker delta function.
The wall shear stress relation will be:
WSSα = Tαβnβ − (nβTγβnγ)nα (3.78)
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3.2.9 Velocity and wall shear stress validation
Now that we have obtained the optimum resolution for the mesh number and the
time step, we compare the analytical solution with the LBM code’s computational
results. The analytical solutions have been obtained in section 3.3.2, and we use
equations 3.63 and 3.66 to validate the computational results. Fig. 3.8. shows the
validation of the computational code versus the results of analytical solution (equation
3.63), for the center-line velocity. The computational code for the wall shear stress
has been validated in Fig. 3.9. against the analytical solution. Finding a model that
catches the wall shear stress accurately can be a challenging task. In this section, we
compare the results that we get from the LBM and challenge its power by comparing
its results with the results of the finite difference method (FDM). Other computational
models, such as the finite volume method or finite element method (FEM), can also
be used in further research to find the best computational model in studying wall
shear stress. We have studied the wall shear stress in the three boundary cells beside
the wall. This is done because the velocity and the moment at the first boundary cell
are very small, and thus it can introduce larger errors in computing the wall shear
stress. We study the first to third cell to see how the distance from the boundary
cell is effective in reducing the computational error. By looking at Table 3.5. we
can realize the interesting behavior in the second boundary cell where we observe the
least computational error in the wall shear stress value. This can only be seen in the
LBM and the error grows in FDM by moving normal to the boundary cell. In Fig.
3.10. you can see the comparison between the results of the computational code and
the analytical solution. The analytical solution for the WSS in parallel plates is also
added to study the effect of the corners. We have used the results of equation 3.68
in order to plot the wall shear stress between parallel plates. In geometries where
the width (a) is much higher than the height (b), we must see the same behavior in
velocity and consequently, the wall shear stress as we see in the flow between parallel
plates.
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Fig. 3.8. The comparison between the velocities at the center-line
using analytical solution (equation (3.63)), and the computational
code, Error=0.1 %
Table 3.5.
wall shear stress accuracy study
Velocity error(%) LBM WSS error(%) FDM WSS error (%)
1st boundary cell 0.1 % 0.1% 2.7 %
2nd boundary cell 0.1 % 0.06 % 2.9 %
3nd boundary cell 0.1 % 0.25 % 3.1 %
3.3 Conclusion
The wall shear stress is a parameter that depends on the gradient of the velocity
beside the wall thus to obtain an accurate wall shear stress, we need to have an
accurate model that predicts the velocity very well. The Importance of this work is
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Fig. 3.9. The comparison between the wall shear stress at the lower
(Or upper) wall using analytical solution (equation (3.66)), and the
computational cod, Error=0.1 %
that we have calculated the wall shear stress and investigated it in detail. Although
the results in the first cell have small error (less than one percent), the error in
the second cell is even smaller. These shear stress results has came directly from
the lattice Boltzmann method and were compared to the results of finite difference
method. The results show that the lattice Boltzmann method is highly more accurate
than the results in the finite difference method. In all three boundary cells that we
have studied, the error of the model coming from LBM is smaller compared to the
results coming from the FDM. We have also indicated that the wall shear stress result
of parallel plates and rectangular channel have relatively the same value at the mid-
section of the wall. It can be predicted that for larger geometries, the wall shear stress
at mid-section of the geometry stays close to the wall shear stress in parallel plates.
However, this immediately changes while we move along the X axis and get far from
the midsection of the wall due to the effects of the side walls. The wall shear stress
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Fig. 3.10. The validation results for the wall shear stress along the
X axis. The LBM simulation is done for case (a) and the results of
WSS are measured along the red line in the X axis and compared to
the analytical solution shown with the square symbol.
drops to zero close to the corners. This result makes sense on account of the fact
that close to the corner the velocity is zero in X and Y direction (non-slip boundary
condition close to the wall) and consequently there is no gradient of velocity in any
direction along X − Y plane.
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4. SUMMARY
This work studied the computational fluid dynamics and its application in two differ-
ent bio-engineering cases. At the beginning we dealt with finding an optimum model
to study the drug diffusion in the posterior eye to treat Age-related macular degen-
eration which is chronic disease and is more common in elders. We have covered the
possible treatment methods and determined that using drug implant storage at the
posterior eye is one the methods with least side effects. The current most common
treatment method right now is the direct injection of the drug to the eye which can
have serious side effects such as retinal detachment or internal eye bleeding. By using
CFD, we can get valuable information about the drug behavior during the treatment
and this may replace the common injection method with widely utilized drug im-
plants. After obtaining a good computational model, we use this model to study the
drug delivery after adding a porous divider to the system. We use this porous divider
as a modifier in controlling the drug delivery. This modifier contains several pores and
the pore size and diffusion coefficient are the governing parameters in controlling the
drug delivery. By using the validated computational model we could see the effects
of adding pores to the drug implant. The following questions will remain to answer:
what is the optimum geometry to have a more uniform drug delivery? what are the
effects of drug molecular weight? what is the effect of the pore thickness? these
questions need further research to be answered. We have used the lattice Boltzmann
method to obtain the wall shear stress and velocity in the next part. The second
part tackles with the creation and import of a geometry and building P-value out of
CAD file. The validity of this transforming code has been verified in the second part.
We have obtained a highly accurate model in the lattice Boltzmann to capture the
wall shear stress. We later obtained that the wall shear stress in validation is more
accurate at the second cell right beside the boundary cell. This can be attributed to
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the fact that the velocity at the boundary cell is very small and due to the fact that
wall shear stress is about the velocity gradient at the wall, it is harder to have an
accurate computational model at the boundary.
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